Literature DB >> 9545090

PCR detection of Y-specific sequences in patients with Ullrich-Turner syndrome: clinical implications and limitations.

G R Osipova1, M E Karmanov, S I Kozlova, O V Evgrafov.   

Abstract

Cytogenetic analysis of patients with Ullrich-Turner syndrome (UTS) may fail to detect low levels of Y chromosome mosaicism or Y-derived marker chromosomes. More sensitive polymerase chain reaction (PCR)-based tests have been developed; however, applicability of these data to prognosis of virilization and gonadoblastoma development has not been investigated adequately. We used a multiplex PCR-based method to detect two Y-specific sequences, SRY and AMGLY. Thirteen patients with UTS without cytogenetically detected Y chromosomes were studied. Y-specific sequences were detected in 5 patients by multiplex PCR. A cryptic translocation involving the Y chromosome was found in one patient with severe virilization of external genitalia and a male phenotype. Y chromosomal mosaicism was detected in peripheral blood and in both gonads of one patient, and only in the left gonad of another patient. Existence of a Y-derived marker was demonstrated in 2 patients, one of whom had no testicular tissue or virilization. Consistent with previous reports, we conclude that PCR is more sensitive than classical cytogenetic analysis and detects patients with Y-specific sequences in blood cells. However, the absence of Y-specific material in blood is not a sufficient reason to reject surgical treatment in case of virilization.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9545090

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  2 in total

1.  Risk of Gonadoblastoma Development in Patients with Turner Syndrome with Cryptic Y Chromosome Material.

Authors:  Ahreum Kwon; Sei Eun Hyun; Mo Kyung Jung; Hyun Wook Chae; Woo Jung Lee; Tae Hyuk Kim; Duk Hee Kim; Ho-Seong Kim
Journal:  Horm Cancer       Date:  2017-03-27       Impact factor: 3.869

2.  Y-chromosome markers in Turner syndrome: Screening of 130 patients.

Authors:  A Sallai; J Sólyom; M Dobos; J Szabó; Z Halász; L Ságodi; T Niederland; A Kozári; R Bertalan; P Ugocsai; G Fekete
Journal:  J Endocrinol Invest       Date:  2009-07-21       Impact factor: 4.256

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.